We are live on ! Find out more
DCM

DME Capital Management Portfolio holdings

AUM $3.91B
1-Year Est. Return 36.1%
This Fund
S&P 500
This Quarter Est. Return
+6.38%
1 Year Est. Return
+36.1%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2.33B
AUM Growth
+$352M
Cap. Flow
+$253M
Cap. Flow %
10.89%
Top 10 Hldgs %
74.25%
Holding
37
New
4
Increased
8
Reduced
8
Closed
3

Top Sells

Rank Stock Value
1
VTRS icon
Viatris
VTRS
+$52.3M
2
DLTR icon
Dollar Tree
DLTR
+$32.8M
3
PTON icon
Peloton Interactive
PTON
+$31.3M
4
KD icon
Kyndryl
KD
+$29.8M
5
ROIV icon
Roivant Sciences
ROIV
+$9.65M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 39.02%
2 Energy 13.88%
3 Industrials 12.81%
4 Healthcare 10.21%
5 Technology 9.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GRBK icon
1
Green Brick Partners
GRBK
$2.96B
$595M 25.59%
9,467,383
– –
FLR icon
2
Fluor
FLR
$6.74B
$196M 8.42%
+3,819,580
New +$152M
CNR
3
Core Natural Resources Inc
CNR
$4.42B
$150M 6.46%
2,155,640
-53,000
-2% -$3.77M
BHF icon
4
Brighthouse Financial
BHF
$3.06B
$148M 6.38%
2,760,097
-41,000
-1% -$2.3M
KD icon
5
Kyndryl
KD
$2.53B
$139M 5.97%
3,311,297
-823,910
-20% -$29.8M
PENN icon
6
PENN Entertainment
PENN
$2.1B
$134M 5.76%
7,494,440
+1,226,000
+20% +$19.2M
CNH
7
CNH Industrial
CNH
$21.1B
$102M 4.39%
7,872,610
-203,930
-3% -$2.52M
GPK icon
8
Graphic Packaging
GPK
$2.78B
$99.2M 4.26%
4,705,950
+3,658,850
+349% +$84.6M
DHT icon
9
DHT Holdings
DHT
$3.51B
$82.4M 3.54%
7,620,934
+1,010,000
+15% +$11.1M
TECK icon
10
Teck Resources
TECK
$32.4B
$80.8M 3.47%
2,000,000
– –
HPQ icon
11
HP
HPQ
$28.2B
$73.8M 3.17%
3,018,770
– –
TEVA icon
12
Teva Pharmaceutical Industries Limited
TEVA
$45.7B
$63.3M 2.72%
3,778,777
+3,210,577
+565% +$51.8M
CPRI icon
13
Capri Holdings
CPRI
$1.72B
$61.6M 2.65%
3,479,107
– –
LBTYA icon
14
Liberty Global Class A
LBTYA
$3.22B
$52.3M 2.25%
5,220,502
– –
GLD icon
15
SPDR Gold Trust
GLD
$145B
$51.6M 2.22%
169,411
-10,740
-6% -$3.25M
ROIV icon
16
Roivant Sciences
ROIV
$25.9B
$51.3M 2.21%
4,551,057
-890,110
-16% -$9.65M
WFRD icon
17
Weatherford International
WFRD
$6.08B
$48.3M 2.08%
960,810
+504,171
+110% +$23.4M
CNC icon
18
Centene
CNC
$30.5B
$45.6M 1.96%
839,170
+291,600
+53% +$17.1M
SDRL icon
19
Seadrill
SDRL
$2.85B
$41.7M 1.79%
1,588,828
– –
CI icon
20
Cigna
CI
$71.9B
$31M 1.33%
+93,750
New +$30.2M
ACHC icon
21
Acadia Healthcare
ACHC
$2.62B
$19.6M 0.84%
865,011
+744,151
+616% +$17.6M
VSXY
22
Victoria's Secret
VSXY
$6.61B
$16.4M 0.71%
+887,750
New +$17.4M
LKFT
23
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.92B
$13.5M 0.58%
482,746
– –
COYA icon
24
Coya Therapeutics
COYA
$119M
$9.47M 0.41%
1,646,440
– –
SNX icon
25
TD Synnex
SNX
$20.8B
$4.51M 0.19%
33,270
-12,945
-28% -$1.52M

Similar funds

DME Capital Management's Q2 2025 Portfolio in Review

As of Q2 2025, DME Capital Management held 37 positions worth $2.33B, up 18% from $1.97B the previous quarter. Its ten largest holdings account for 74% of the portfolio.

DME Capital Management deployed $253M of net new capital in Q2 2025, opening 4 new positions and adding to 8 existing holdings. Its largest new stake was Fluor: 3,819,580 shares worth $196M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 39% of assets, down from 40% a quarter earlier, followed by Energy and Industrials.

On the sell side, the largest reduction was Peloton Interactive, an estimated $31.3M trimmed.

  • DME Capital Management's largest Q2 2025 buy was Fluor: 3,819,580 shares worth $196M.
  • DME Capital Management added most to Graphic Packaging in Q2 2025, an estimated $84.6M increase.
  • DME Capital Management's biggest Q2 2025 reduction was Peloton Interactive, cutting an estimated $31.3M.
  • DME Capital Management fully exited Viatris in Q2 2025, selling an estimated $52.3M.
  • DME Capital Management's ten largest holdings make up 74% of its $2.33B portfolio in Q2 2025.
  • DME Capital Management opened 4 new positions and closed 3 in Q2 2025.
  • DME Capital Management's portfolio value rose 18% quarter-over-quarter to $2.33B.

Based on DME Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.